The IASLC 2026 Targeted Therapies of Lung Cancer (TTLC) meeting is a premier international conference scheduled for February 18–21, 2026, in Huntington Beach, California.

Organized by the International Association for the Study of Lung Cancer (IASLC), this landmark event brings together global experts, clinicians, and researchers to share the latest breakthroughs in preclinical research and data from cutting-edge clinical trials. The symposium serves as a critical forum for discussing how emerging molecular targets and novel treatments are actively transforming clinical practice and treatment guidelines for thoracic malignancies.

Register.